A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

M. D. Green, Heinz Koelbl, José Baselga et al. · Annals of Oncology · 2002

Cited by 586 works. doi:10.1093/annonc/mdg019

Authors

References